Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A S Ismail

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Frontiers in Physiology|February 26, 2019
Annexin II Light Chain p11 Interacts With ENaC to Increase Functional Activity at the MembraneTanya T Cheung, Noor A S Ismail, Rachel Moir, et al.
Cancer Chemotherapy and Pharmacology|May 11, 2001
Human plasma carboxylesterase and butyrylcholinesterase enzyme activity: correlations with SN-38 pharmacokinetics during a prolonged infusion of irinotecanA A Guemei, J Cottrell, R Band, et al.
Cancer Chemotherapy and Pharmacology|March 28, 2001
Pharmacokinetics and pharmacodynamic effects of 5-fluorouracil given as a one-hour intravenous infusionJ L Grem, M Quinn, A S Ismail, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 19, 2012
Predictors of ischaemic heart disease in a Malaysian population with the metabolic syndromeT P Yeow, A S Khir, A A-S Ismail, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Phase I and pharmacologic study of irinotecan administered as a 96-hour infusion weekly to adult cancer patientsC H Takimoto, G Morrison, N Harold, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Frontiers in Physiology|February 26, 2019
Annexin II Light Chain p11 Interacts With ENaC to Increase Functional Activity at the MembraneTanya T Cheung, Noor A S Ismail, Rachel Moir, et al.
Cancer Chemotherapy and Pharmacology|May 11, 2001
Human plasma carboxylesterase and butyrylcholinesterase enzyme activity: correlations with SN-38 pharmacokinetics during a prolonged infusion of irinotecanA A Guemei, J Cottrell, R Band, et al.
Cancer Chemotherapy and Pharmacology|March 28, 2001
Pharmacokinetics and pharmacodynamic effects of 5-fluorouracil given as a one-hour intravenous infusionJ L Grem, M Quinn, A S Ismail, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 19, 2012
Predictors of ischaemic heart disease in a Malaysian population with the metabolic syndromeT P Yeow, A S Khir, A A-S Ismail, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Phase I and pharmacologic study of irinotecan administered as a 96-hour infusion weekly to adult cancer patientsC H Takimoto, G Morrison, N Harold, et al.
Pageof 2